Riskpilot← Back to searchSign inGet full accessLIFE NORGE AS
ASActiveOrg 977222672Pottemakerveien 10, 0954 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 199717 employeeswww.lifenorge.no
Revenue 2023
NOK 44,4M
-45% vs 2022
EBITDA margin
0.8%
-80% vs 2022
Equity ratio
7.8%
Financial strength
Net profit 2023
NOK 102K
-88% vs 2022
| Revenue | NOK 44,4M | -45% |
| EBITDA | NOK 361K | -80% |
| Net profit | NOK 102K | -88% |
| Total assets | NOK 25,8M | +17% |
| Equity | NOK 2M | +60% |
| Employees | 17 | — |
Legal name
LIFE NORGE AS
Org number
977222672
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. februar 1997
Share capital
NOK 350 000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Address
Pottemakerveien 10, 0954 Oslo
Phone
+4722744107
Email
salg@lifenorge.no
Website
www.lifenorge.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 15 881 | 33 115 | 29 654 | 80 784 | 44 362 |
| Staff expenses | −4 498 | −6 565 | −5 272 | −7 907 | −8 898 |
| EBITDA | −636 | 1 824 | 315 | 1 835 | 361 |
| Depreciation & amort. | −41 | −199 | −361 | −529 | −415 |
| EBIT | −678 | 1 625 | −46 | 1 306 | −54 |
| Net financials | −193 | −530 | −367 | −182 | 184 |
| Profit before tax | −870 | 1 096 | −413 | 1 124 | 131 |
| Tax | −188 | 128 | −91 | 257 | 29 |
| Net profit | −683 | 967 | −322 | 867 | 102 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 6 150 | 11 211 | 13 029 | 22 024 | 25 815 |
| Equity | −95 | 710 | 388 | 1 256 | 2 014 |
| Long-term debt | 767 | 4 284 | 3 585 | 3 164 | 2 812 |
| Short-term debt | 5 479 | 6 216 | 9 055 | 17 605 | 20 989 |
| Total debt | 6 245 | 10 500 | 12 640 | 20 768 | 23 801 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20192023
Equity ratio
7.8%
This company
38.2%
Market median
-80% vs market
20192023
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20192023
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20192023
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20192023
Debt / equity
11.82×
This company
0.62×
Market median
-1806% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norges Røde Kors
LIFE NORGE AS Board members of LIFE NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sture Krey Skjæret | Chief Executive Officer | 0 companies |
| Jon Nerheim | Board of Directors | 0 companies |
| Fredrik Andre Åsebø | Chairman | 0 companies |
| Lars Atle Skorpen | Board of Directors | 0 companies |
| Ronny Vestbø | Board of Directors | 0 companies |